Tvardi Therapeutics (TVRD) Cash & Equivalents (2013 - 2026)
Tvardi Therapeutics (TVRD) posted Cash & Equivalents of $15.8 million for Q2 2026, down 23.5% from $20.65 million a year earlier and down 20.6% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Tvardi Therapeutics' Cash & Equivalents came in at $20.73 million, down 34.4% from FY2024.
- Annual Cash & Equivalents has declined for three consecutive years, with a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- In prior years, Tvardi Therapeutics' Cash & Equivalents was $31.61 million in FY2024 (-38.9%), $51.78 million in FY2023 (-18.8%), $63.74 million in FY2022 (+373.8%) and $13.45 million in FY2021 (-57.5%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q4 2021.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last 11 quarters, with an average decline of 38.4% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2022, with growth of 373.8%; the weakest was Q3 2021, with a decline of 69.5%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $19.9 million (Q1 2026), $20.73 million (Q4 2025) and $21.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Tvardi Therapeutics | 10.79 Mn | 10.79 Mn | - | 15.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.80 Mn |
| Mar 31, 2026 | 19.90 Mn |
| Dec 31, 2025 | 20.73 Mn |
| Sep 30, 2025 | 21.42 Mn |
| Jun 30, 2025 | 20.65 Mn |
| Mar 31, 2025 | 34.22 Mn |
| Dec 31, 2024 | 31.61 Mn |
| Sep 30, 2024 | 37.06 Mn |
| Jun 30, 2024 | 49.24 Mn |
| Mar 31, 2024 | 47.00 Mn |
| Dec 31, 2023 | 51.78 Mn |
| Sep 30, 2023 | 62.88 Mn |
| Jun 30, 2023 | 58.25 Mn |
| Mar 31, 2023 | 47.39 Mn |
| Dec 31, 2022 | 63.74 Mn |
| Sep 30, 2022 | 42.81 Mn |
| Jun 30, 2022 | 46.72 Mn |
| Mar 31, 2022 | 21.36 Mn |
| Dec 31, 2021 | 13.45 Mn |
| Sep 30, 2021 | 22.99 Mn |
API Access
Tvardi Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();